stockrow
Friday 6 November 2026
Export RGC’s income statement to Excel — free account
Regencell Bioscience Holdings Limited
RGC Healthcare Drug Manufacturers Specialty & Generic
5.16
0.26
−4.80%
Follow RGC
Alert me
Regencell Bioscience Holdings Limited (RGC) Current ratio
Regencell Bioscience Holdings Limited's current ratio at the end of the quarter to 30 June 2026 was 10.8×. Over the past ten years it has ranged from 0.0× (fiscal 2021) to 41.9× (fiscal 2024); the current reading is higher than 63% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 2.4× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2026 | 10.8× | 45.79% |
| FY2025 | 7.4× | (82.37%) |
| FY2024 | 41.9× | 118.87% |
| FY2023 | 19.1× | (32.72%) |
| FY2022 | 28.5× | 184,709.74% |
| FY2021 | 0.0× | (87.41%) |
| FY2020 | 0.1× | 4.62% |
| FY2019 | 0.1× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 10.8× | 660.85% |
| Dec 2025 | 1.4× | (80.84%) |
| Jun 2025 | 7.4× | (82.38%) |
| Jun 2024 | 41.9× | 118.91% |
| 8 more quarters | Free account |
Against its own ten years
Low 0.0×
High 41.9×
Ten-year median
9.1×
Current reading's percentile
63
Current ratio against peers
| Company | Current ratio |
|---|---|
| AMLX Amylyx Pharmaceuticals, Inc. compare | 12.1× |
| RGC Regencell Bioscience Holdings Limited | 10.8× |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | 5.6× |
| TRLV Trulieve Cannabis Corp. compare | 5.5× |
| PBH Prestige Consumer Healthcare Inc. compare | 2.9× |
| BCRX BioCryst Pharmaceuticals, Inc. compare | 2.7× |
| PRGO Perrigo Company plc compare | 2.4× |
| XERS Xeris Biopharma Holdings, Inc. compare | 2.2× |
| ALVO Alvotech compare | 1.6× |
| Drug Manufacturers Specialty & Generic industry median | 2.4× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)